European Health Interview Survey (EHIS) (European Union): Difference between revisions

Revision as of 14:17, 8 December 2023

Sponsor, manager or home institution: Eurostat.

Primary purpose: To measure the health status, health determinants, and healthcare access among EU citizens in a harmonized and comparable manner across Member States.

Type of information: Data Dictionary:European Health Interview Survey (EHIS).

Data level: respondent level.

Number of Records: Population aged 15 or over living in private households residing in the territory of the EU countries.

Date Range: 2006-2020.

Cancer Areas of Interest: tracheal cancer (C33); bronchial and lung cancer (C34); colon cancer (C18-C20); breast cancer (C50); cervical cancer (C53); prostate cancer (C61).

Data access: partially publicly available [1]. Instructions to request data for restricted content [2].

Contact information: Information [3].

@@ Line 1: / Line 1: @@
 {{forresearchers}}
-Go back to [[European Union - wide Resources]] page
+Go back to [[European Union]] page
-'''Sponsor, manager or home institution:''' Eurostat.
+'''Sponsor, manager or home institution:''' [[dataOwner::Eurostat]].
 '''Primary purpose:''' To measure the health status, health determinants, and healthcare access among EU citizens in a harmonized and comparable manner across Member States.
-'''Type of information:''' [[Data Dictionary:European Health Interview Survey (EHIS)]]. Health status: General health status (Minimum European health module): self-perceived health, chronic morbidity and activity limitation; Disease-specific morbidity; Accidents and injuries; Health-related absenteeism from work; Physical and sensory functional limitations (also cognitive limitations in wave 3); Difficulties in personal care activities / activities of daily living and help received/needed; Household activities / Instrumental activities of daily living and help received/needed; Pain; Aspect of mental health (psychological distress and mental well-being in the first wave, depressive symptoms in the second and third waves); Work-related health problems (only in the first wave). Health care: Hospitalisation (in-patient and day care); Consultations with doctors and dentists; Visits to specific health professionals; Use of home care services; Use of medicines; Healthcare preventive actions; Unmet needs for health care; Out-of-pocket payments for medical care (only in the first wave); Satisfaction with services provided by healthcare providers (only in the first wave); Visits to specific categories of alternative medicine practitioners (only in the first wave). Health determinants: Height and weight; Physical activity/exercise; Consumption of fruits, vegetables and juice; Drinking sugar-sweetened soft drinks (only in the third wave); Tobacco smoking behaviour and exposure to tobacco smoke; Use of e-cigarettes or similar electronic devices (only in the third wave); Alcohol consumption; Social support; Provision of informal care or assistance (only in the second and third waves); Illicit drug use (only in the first wave); Environment (only in the first wave); Background variables on demography and socio-economic characteristics. Age; Sex; Educational attainment level; Income quintile group; Degree of urbanization; Country of birth; Country of citizenship; Activity limitation.
+'''Type of information:''' [[hasDataDictionary::Data Dictionary:European Health Interview Survey (EHIS)]].
-'''Data level:''' Respondent level.
+'''Data level:''' [[dataLevel::respondent level]].
 '''Number of Records:''' Population aged 15 or over living in private households residing in the territory of the EU countries.
-'''Date Range:''' 2006-2020.
+'''Date Range:''' [[dataStart::2006]]-[[dataEnd::2020]].
-'''Cancer Areas of Interest:''' Malignant neoplasm of the trachea (C33); Malignant neoplasm of the bronchus and lung (C34); Malignant neoplasm of the colon (C18); Malignant neoplasm of the rectosigmoid junction (C19); Malignant neoplasm of the rectum (C20); Malignant neoplasm of the breast (C50); Malignant neoplasm of the cervix uteri (C53); Malignant neoplasm of the prostate (C61).
+'''Cancer Areas of Interest:''' [[hasCancerAreasList::tracheal cancer (C33)]]; [[hasCancerAreasList::bronchial and lung cancer (C34)]]; [[hasCancerAreasList::colon cancer (C18-C20)]]; [[hasCancerAreasList::breast cancer (C50)]]; [[hasCancerAreasList::cervical cancer (C53)]]; [[hasCancerAreasList::prostate cancer (C61)]].
-'''Data access:''' Partially publicly available [https://ec.europa.eu/eurostat/cache/metadata/en/hlth_det_esms.htm]. Instructions to request data for restricted content [https://ec.europa.eu/eurostat/web/microdata].
+'''Data access:''' [[dataAvailability::partially publicly available]] [https://ec.europa.eu/eurostat/cache/metadata/en/hlth_det_esms.htm]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://ec.europa.eu/eurostat/web/microdata]]].
 '''Contact information:''' Information [https://ec.europa.eu/eurostat/cache/metadata/en/hlth_det_esms.htm#contact1678715439901].